Cargando…
Capillary leak syndrome induced by neoadjuvant cisplatin and gemcitabine in a patient with bladder cancer
Capillary leak syndrome (CLS) is a rare disorder associated with an increased capillar permeability due to an endothelial damage, causing leakage of plasma and proteins into the interstitial compartment. CLS is characterized by rapidly developing edema, hypotension and hypoproteinemia. We observed C...
Autores principales: | Massafra, Marco, Passalacqua, Maria Ilenia, Lupo, Giuseppe, Altavilla, Giuseppe, Santarpia, Mariacarmela |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7575506/ https://www.ncbi.nlm.nih.gov/pubmed/33101987 http://dx.doi.org/10.1016/j.eucr.2020.101461 |
Ejemplares similares
-
Immunotherapeutic Advances for NSCLC
por: Massafra, Marco, et al.
Publicado: (2021) -
Gemcitabine-induced chronic systemic capillary leak syndrome
por: Bajwa, Ravneet, et al.
Publicado: (2017) -
A narrative review of MET inhibitors in non-small cell lung cancer with MET exon 14 skipping mutations
por: Santarpia, Mariacarmela, et al.
Publicado: (2021) -
Gemcitabine Plus Cisplatin Versus Non-Gemcitabine and Cisplatin Regimens as Neoadjuvant Treatment for Cholangiocarcinoma Patients Prior to Liver Transplantation: An Institution Experience
por: Abdelrahim, Maen, et al.
Publicado: (2022) -
Curative Effect and Survival Assessment Comparing Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin and Cisplatin as Neoadjuvant Therapy for Bladder Cancer: A Systematic Review and Meta-Analysis
por: Wu, Tiange, et al.
Publicado: (2021)